HK StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

MIRXES-B

59.800

-2.000-3.24%

Volume:676.00K

Turnover:40.65M

Market Cap:16.50B

PE:-77.76

High:62.150

Open:62.150

Low:59.000

Close:61.800

52wk High:77.300

52wk Low:27.050

Shares:276.00M

HK Float Shares:276.00M

Volume Ratio:1.71

T/O Rate:0.24%

Dividend:- -

Dividend Rate:- -

EPS(LYR):-0.769

ROE:--

ROA:-51.53%

PB:20.34

PE(LYR):-77.76

PS:100.26

Loading ...

Overview Company News Filings

Mirxes (2629) Extends Cornerstone Lock-Up Period and Announces Executive Director Change

Bulletin Express

Mirxes (Stock Code: 2629) Announces Board Composition and Committee Roles

Bulletin Express

Mirxes Holding Files Board of Directors List to HKEX

MIRXES-B (02629): He Haojie Steps Down as Executive Director

Mirxes Holding Announces Retirement of Executive Director Ho Hou Chiat

Mirxes Holding - Ho Hou Chiat, Isaac Retires as Executive Director

THOMSON REUTERS

Founder Securities Initiates Coverage on MIRXES-B (02629) with "Recommend" Rating as GASTROClear Gains Approval

Mirxes Holding (02629) Announces Monthly Return for October 2025

Bulletin Express

BRIEF-MiRXES Holding Says Gastrocleartm Receives China Nmpa Ivd Registration Certificate

MIRXES-B (02629): GASTROClear™ Receives NMPA Approval for Gastric Cancer Screening IVD Registration in China

Mirxes Holding Co Ltd receives China NMPA approval for GASTROClear gastric cancer screening test

Mirxes Holding Co Ltd - Gastrocleartm Receives China Nmpa Ivd Registration Certificate for Gastric Cancer Screening

THOMSON REUTERS

Mirxes Unit Forms JV Firm for Cancer Detection Testing

MT Newswires Live

BRIEF-Mirxes Holding Co's Unit Enters JV Agreement With Xeraya Opportunities Fund PCC

MIRXES-B (02629) to Establish Joint Venture for Cancer Early Detection and Nucleic Acid-Based Testing Research, Development, and Commercialization in Malaysia

Mirxes Holding Co. Ltd. Forms Joint Venture with Xeraya to Launch MYRNA Diagnostics in Malaysia

Mirxes Holding Co - Unit Enters Jv Agreement With Xeraya Opportunities Fund Pcc to Establish Myrna Diagnostics Sdn

THOMSON REUTERS

Mirxes Holding - Jv to Focus on Cancer Detection Tests in Malaysia

THOMSON REUTERS

Hong Kong Stock Connect Biotech Stocks Trade Mixed in Positive Territory, MIRXES-B Surges 25% in Afternoon Session! Multi-Billion Private Equity Firms Increase Biotech Exposure on Dips, Pure-Play Biotech R&D ETF 520880 Attracts Strong Capital Inflows

Hong Kong Stock Alert | MIRXES-B (02629) Surges Over 35% Intraday to Record High as Singapore Cancer Screening Company Gets Added to Stock Connect

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/02629/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02629","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02629\",,,,,undefined,":{"symbol":"02629","market":"HK","secType":"STK","nameCN":"MIRXES-B","latestPrice":59.8,"timestamp":1763102186856,"preClose":61.8,"halted":0,"volume":676000,"delay":0,"floatShares":276000000,"shares":276000000,"eps":-0.76899,"marketStatus":"Trading","change":-2,"latestTime":"11-14 14:36:59","open":62.15,"high":62.15,"low":59,"amount":40649375,"amplitude":0.050971,"askPrice":59.85,"askSize":800,"bidPrice":59.8,"bidSize":9000,"shortable":3,"etf":0,"ttmEps":-0.558151,"tradingStatus":2,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1763107800000},"marketStatusCode":2,"adr":0,"listingDate":1747929600000,"exchange":"SEHK","adjPreClose":61.8,"openAndCloseTimeList":[[1763083800000,1763092800000],[1763096400000,1763107200000]],"volumeRatio":1.713512,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02629\",,,,,undefined,":{"symbol":"02629","floatShares":276000000,"roa":"-51.53%","roe":"--","lyrEps":-0.76899,"volumeRatio":1.713512,"shares":276000000,"dividePrice":0,"high":62.15,"amplitude":0.050971,"preClose":61.8,"low":59,"week52Low":27.05,"pbRate":"20.34","psRate":"100.26","week52High":77.3,"institutionHeld":0,"latestPrice":59.8,"committee":0.836735,"eps":-0.76899,"divideRate":0,"volume":676000,"delay":0,"ttmEps":-0.558151,"open":62.15,"prevYearClose":23.3,"prevWeekClose":63.85,"prevMonthClose":67.95,"prevQuarterClose":61.4,"fiveDayClose":63.85,"twentyDayClose":70.6,"sixtyDayClose":48.36},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02629\",params:#limit:5,,,undefined,":[{"date":"2025-08-25","symbol":"02629","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756085400000,"name":null,"time":"","dateTimestamp":1756051200000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02629\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02629\",market:\"HK\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02629\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02629","date":"2025-11-13","current":-108.841514,"percent":0.252101,"low":-34.231253,"twenty":-29.342142,"median":-16.014471,"eighty":-11.200928,"high":-10.373055,"avg":-18.871164,"sd":8.301158,"marketCap":16889768010},"quantilePoints":[{"date":"2025-05-30","current":-10.615633,"twenty":-10.820807,"median":-10.729406,"eighty":-10.614136,"marketCap":7683833445},{"date":"2025-06-06","current":-10.752673,"twenty":-10.811558,"median":-10.713624,"eighty":-10.576495,"marketCap":7789091437},{"date":"2025-06-13","current":-10.566273,"twenty":-10.761884,"median":-10.608146,"eighty":-10.555773,"marketCap":7657518947},{"date":"2025-06-20","current":-12.580768,"twenty":-10.923966,"median":-10.686264,"eighty":-10.56693,"marketCap":9117973591},{"date":"2025-06-27","current":-12.5082,"twenty":-12.340962,"median":-10.752673,"eighty":-10.581112,"marketCap":9065344595},{"date":"2025-07-04","current":-11.927039,"twenty":-12.355485,"median":-10.862871,"eighty":-10.586526,"marketCap":8644312625},{"date":"2025-07-11","current":-11.200931,"twenty":-12.261215,"median":-11.092147,"eighty":-10.600008,"marketCap":8118022663},{"date":"2025-07-18","current":-11.402889,"twenty":-12.217621,"median":-11.255392,"eighty":-10.612638,"marketCap":8262752403},{"date":"2025-07-25","current":-11.182791,"twenty":-12.077376,"median":-11.219171,"eighty":-10.651065,"marketCap":8104865414},{"date":"2025-08-01","current":-11.128301,"twenty":-11.949795,"median":-11.200931,"eighty":-10.68858,"marketCap":8065393667},{"date":"2025-08-08","current":-11.930929,"twenty":-11.952128,"median":-11.246394,"eighty":-10.71678,"marketCap":8646944075},{"date":"2025-08-15","current":-16.088166,"twenty":-12.119645,"median":-11.255421,"eighty":-10.743366,"marketCap":11636271059},{"date":"2025-08-22","current":-16.714103,"twenty":-12.435432,"median":-11.355275,"eighty":-10.780307,"marketCap":12057303029},{"date":"2025-08-29","current":-19.927844,"twenty":-12.534962,"median":-11.42267,"eighty":-10.837215,"marketCap":11841524145},{"date":"2025-09-05","current":-19.639174,"twenty":-15.876379,"median":-11.649361,"eighty":-10.890619,"marketCap":11678374256},{"date":"2025-09-12","current":-19.500462,"twenty":-16.755738,"median":-11.763715,"eighty":-10.953665,"marketCap":11578379164},{"date":"2025-09-19","current":-23.413745,"twenty":-18.486553,"median":-11.918008,"eighty":-11.048541,"marketCap":13880897747},{"date":"2025-09-26","current":-25.667378,"twenty":-19.506384,"median":-11.983928,"eighty":-11.09201,"marketCap":15222937150},{"date":"2025-10-03","current":-33.789751,"twenty":-19.751895,"median":-12.054377,"eighty":-11.092062,"marketCap":20046350866},{"date":"2025-10-10","current":-31.081374,"twenty":-21.012535,"median":-12.217733,"eighty":-11.099357,"marketCap":18433897286},{"date":"2025-10-17","current":-30.795303,"twenty":-24.490925,"median":-12.444526,"eighty":-11.135571,"marketCap":18242589234},{"date":"2025-10-24","current":-29.480903,"twenty":-26.341784,"median":-12.526178,"eighty":-11.168279,"marketCap":17463692166},{"date":"2025-10-31","current":-31.356875,"twenty":-27.937945,"median":-12.547947,"eighty":-11.182791,"marketCap":18570545895},{"date":"2025-11-07","current":-29.443096,"twenty":-29.330719,"median":-14.698348,"eighty":-11.200916,"marketCap":17450027305},{"date":"2025-11-13","current":-28.515386,"twenty":-29.342142,"median":-16.014471,"eighty":-11.200928,"marketCap":16889768010}],"updateTime":1763084842842},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02629\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1165597977","title":"Mirxes (2629) Extends Cornerstone Lock-Up Period and Announces Executive Director Change","url":"https://stock-news.laohu8.com/highlight/detail?id=1165597977","media":"Bulletin Express","labels":["executive","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1165597977?lang=en_us&edition=fundamental","pubTime":"2025-11-13 17:23","pubTimestamp":1763025829,"startTime":"0","endTime":"0","summary":"Mirxes Holding Company Limited (stock code: 2629) announced an extension of the lock-up period for its cornerstone investors. Originally set for six months from the listing date, the restriction will...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02629"],"gpt_icon":0},{"id":"1156670002","title":"Mirxes (Stock Code: 2629) Announces Board Composition and Committee Roles","url":"https://stock-news.laohu8.com/highlight/detail?id=1156670002","media":"Bulletin Express","labels":["executive","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1156670002?lang=en_us&edition=fundamental","pubTime":"2025-11-13 17:22","pubTimestamp":1763025759,"startTime":"0","endTime":"0","summary":"Mirxes Holding Company Limited (Stock Code: 2629) released details on November 13, 2025, regarding its Board of Directors and the structure of three committees. The Board comprises Executive...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02629"],"gpt_icon":0},{"id":"2583570225","title":"Mirxes Holding Files Board of Directors List to HKEX","url":"https://stock-news.laohu8.com/highlight/detail?id=2583570225","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583570225?lang=en_us&edition=fundamental","pubTime":"2025-11-13 17:13","pubTimestamp":1763025208,"startTime":"0","endTime":"0","summary":"Mirxes Holding Co. Ltd., incorporated in the Cayman Islands and listed on the Hong Kong Stock Exchange , has filed an updated list of its board of directors and their roles. The Board comprises Executive Directors Dr. Zhou Lihan  and Dr. Zou Ruiyang; Non-executive Directors Dr. Too Heng Phon , Dr. Le Beilin, and Mr. Liu Da; and Independent Non-executive Directors Dr. Lam Sin Lai Judy , Mr. Fang Xiao, and Ms. Ma Andrea Lo Ling. Committee memberships are as follows: - Audit Committee: Dr. Lam Sin Lai Judy , Mr. Fang Xiao , Dr. Too Heng Phon  - Remuneration Committee: Mr. Fang Xiao , Dr. Lam Sin Lai Judy , Ms. Ma Andrea Lo Ling  - Nomination Committee: Ms. Ma Andrea Lo Ling , Dr. Zhou Lihan , Mr. Fang Xiao  The disclosure provides transparency on the governance structure of the company.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251113:nNDL9w0c0D:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02629"],"gpt_icon":0},{"id":"1183682363","title":"MIRXES-B (02629): He Haojie Steps Down as Executive Director","url":"https://stock-news.laohu8.com/highlight/detail?id=1183682363","media":"Stock News","labels":["executive","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1183682363?lang=en_us&edition=fundamental","pubTime":"2025-11-13 17:10","pubTimestamp":1763025024,"startTime":"0","endTime":"0","summary":"MIRXES-B (02629) announced that Mr. He Haojie will step down as an executive director effective November 13, 2025, to dedicate more time and effort to the business development of the group. The...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02629","BK1161"],"gpt_icon":0},{"id":"2583557201","title":"Mirxes Holding Announces Retirement of Executive Director Ho Hou Chiat","url":"https://stock-news.laohu8.com/highlight/detail?id=2583557201","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583557201?lang=en_us&edition=fundamental","pubTime":"2025-11-13 17:06","pubTimestamp":1763024815,"startTime":"0","endTime":"0","summary":"Mirxes Holding Co. Ltd. has announced that Mr. Ho Hou Chiat, Isaac will retire from his position as executive director effective November 13, 2025. The current executive directors are Dr. Zhou Lihan and Dr. Zou Ruiyang.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Mirxes Holding Co. Ltd. published the original content used to generate this news brief on November 13, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251113:nNDL75rKQN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02629","BK1161"],"gpt_icon":0},{"id":"2583557247","title":"Mirxes Holding - Ho Hou Chiat, Isaac Retires as Executive Director","url":"https://stock-news.laohu8.com/highlight/detail?id=2583557247","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583557247?lang=en_us&edition=fundamental","pubTime":"2025-11-13 17:05","pubTimestamp":1763024746,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251113:nFWN3WP0JR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1161","02629"],"gpt_icon":0},{"id":"1118109039","title":"Founder Securities Initiates Coverage on MIRXES-B (02629) with \"Recommend\" Rating as GASTROClear Gains Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=1118109039","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1118109039?lang=en_us&edition=fundamental","pubTime":"2025-11-07 10:48","pubTimestamp":1762483710,"startTime":"0","endTime":"0","summary":"MIRXES-B (02629) was officially included in the Hang Seng Composite Index and the Stock Connect program on September 8, 2025. Given its unique technological edge and significant growth potential in...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0183","BK0122","BK0276","BK0012","BK1161","BK0028","BK0188","601901","02629"],"gpt_icon":0},{"id":"1134947577","title":"Mirxes Holding (02629) Announces Monthly Return for October 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=1134947577","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1134947577?lang=en_us&edition=fundamental","pubTime":"2025-11-06 09:48","pubTimestamp":1762393693,"startTime":"0","endTime":"0","summary":"Mirxes Holding Company Limited (Stock Code: 02629) published its monthly return for the period ended 31 October 2025. According to the announcement, the company’s total authorized share capital...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02629"],"gpt_icon":0},{"id":"2574350904","title":"BRIEF-MiRXES Holding Says Gastrocleartm Receives China Nmpa Ivd Registration Certificate","url":"https://stock-news.laohu8.com/highlight/detail?id=2574350904","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2574350904?lang=en_us&edition=fundamental","pubTime":"2025-10-09 08:35","pubTimestamp":1759970154,"startTime":"0","endTime":"0","summary":"BRIEF-MiRXES Holding Says Gastrocleartm Receives China Nmpa Ivd Registration Certificate Oct 9 (Reuters) - MiRXES Holding Co Ltd 2629.HK:GASTROCLEARTM RECEIVES CHINA NMPA IVD REGISTRATION CERTIFICATE ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251009:nFWN3VP245:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02629","BK1161"],"gpt_icon":0},{"id":"1176160092","title":"MIRXES-B (02629): GASTROClear™ Receives NMPA Approval for Gastric Cancer Screening IVD Registration in China","url":"https://stock-news.laohu8.com/highlight/detail?id=1176160092","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1176160092?lang=en_us&edition=fundamental","pubTime":"2025-10-09 06:28","pubTimestamp":1759962511,"startTime":"0","endTime":"0","summary":"MIRXES-B (02629) announced that its core product GASTROClear™ has received Class III medical device registration approval from China's National Medical Products Administration (NMPA) as an in vitro...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02629"],"gpt_icon":0},{"id":"2574903478","title":"Mirxes Holding Co Ltd receives China NMPA approval for GASTROClear gastric cancer screening test","url":"https://stock-news.laohu8.com/highlight/detail?id=2574903478","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2574903478?lang=en_us&edition=fundamental","pubTime":"2025-10-09 06:18","pubTimestamp":1759961930,"startTime":"0","endTime":"0","summary":"Mirxes Holding Co. Ltd. announced that its core product, GASTROClear, has been granted regulatory approval by the National Medical Products Administration of China  as a Class III Medical Device for non-invasive gastric cancer screening. GASTROClear is the world's first microRNA  blood test approved for the early detection of gastric cancer, assessing risk by detecting 12 gastric cancer-associated miRNA biomarkers. This is the first blood test to receive NMPA approval for gastric cancer screening in China. The product will be deployed in both public and private medical institutions across China, significantly expanding Mirxes' reach in the Chinese gastric cancer screening market.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Mirxes Ho","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251008:nNDL3fjBY1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02629","BK1161"],"gpt_icon":0},{"id":"2574903147","title":"Mirxes Holding Co Ltd - Gastrocleartm Receives China Nmpa Ivd Registration Certificate for Gastric Cancer Screening","url":"https://stock-news.laohu8.com/highlight/detail?id=2574903147","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2574903147?lang=en_us&edition=fundamental","pubTime":"2025-10-09 06:14","pubTimestamp":1759961694,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251008:nFWN3VP245:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["02629","BK1161"],"gpt_icon":0},{"id":"2573085676","title":"Mirxes Unit Forms JV Firm for Cancer Detection Testing","url":"https://stock-news.laohu8.com/highlight/detail?id=2573085676","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573085676?lang=en_us&edition=fundamental","pubTime":"2025-10-06 18:49","pubTimestamp":1759747786,"startTime":"0","endTime":"0","summary":"Mirxes  unit Mirxes International entered into an agreement with Xeraya Opportunities Fund PCC to form a joint venture named MYRNA DIAGNOSTICS, a Monday Hong Kong bourse filing said.The two parties will contribute $2 million and $3 million to the JV firm and hold a 40% and 60% stake, respectively, according to the micro ribonucleic acid technology company.The JV company will engage in the R&D, commercialization, and obtaining of regulatory approval for cancer early detection and other nucleic acid-based tests in Malaysia.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1161","02629"],"gpt_icon":0},{"id":"2573167561","title":"BRIEF-Mirxes Holding Co's Unit Enters JV Agreement With Xeraya Opportunities Fund PCC","url":"https://stock-news.laohu8.com/highlight/detail?id=2573167561","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573167561?lang=en_us&edition=fundamental","pubTime":"2025-10-06 18:02","pubTimestamp":1759744949,"startTime":"0","endTime":"0","summary":"BRIEF-Mirxes Holding Co's Unit Enters JV Agreement With Xeraya Opportunities Fund PCCOct 6  - MiRXES Holding Co Ltd 2629.HK:UNIT ENTERS JV AGREEMENT WITH XERAYA OPPORTUNITIES FUND PCC TO ESTABLISH MYRNA DIAGNOSTICS SDNJV TO FOCUS ON CANCER DETECTION TESTS IN MALAYSIAFurther company coverage: 2629.HK ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251006:nFWN3VN1ML:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02629","BK1161"],"gpt_icon":0},{"id":"1192936298","title":"MIRXES-B (02629) to Establish Joint Venture for Cancer Early Detection and Nucleic Acid-Based Testing Research, Development, and Commercialization in Malaysia","url":"https://stock-news.laohu8.com/highlight/detail?id=1192936298","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1192936298?lang=en_us&edition=fundamental","pubTime":"2025-10-06 16:48","pubTimestamp":1759740508,"startTime":"0","endTime":"0","summary":"MIRXES-B (02629) announced that on October 6, 2025, its wholly-owned subsidiary Mirxes International Holding Limited entered into a joint venture agreement with Xeraya Opportunities Fund PCC Limited...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02629","BK1161"],"gpt_icon":0},{"id":"2573209126","title":"Mirxes Holding Co. Ltd. Forms Joint Venture with Xeraya to Launch MYRNA Diagnostics in Malaysia","url":"https://stock-news.laohu8.com/highlight/detail?id=2573209126","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573209126?lang=en_us&edition=fundamental","pubTime":"2025-10-06 16:33","pubTimestamp":1759739630,"startTime":"0","endTime":"0","summary":"Mirxes Holding Co. Ltd. has announced the formation of a joint venture with Xeraya Opportunities Fund PCC Limited. The new entity, MYRNA DIAGNOSTICS SDN. BHD., will be owned 40% by Mirxes International Holding Limited, a wholly-owned subsidiary of Mirxes, and 60% by Xeraya. Both parties will contribute a total of approximately US$5 million in cash to the joint venture, in proportion to their respective shareholdings. The joint venture will focus on research, development, commercialization, and regulatory approval of diagnostic solutions, with the aim of improving early disease detection in Malaysia and the region. The partnership is in line with Mirxes' mission to expand access to innovative diagnostic technologies.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, i","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251006:nNDL1VFJwZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02629"],"gpt_icon":0},{"id":"2573958620","title":"Mirxes Holding Co - Unit Enters Jv Agreement With Xeraya Opportunities Fund Pcc to Establish Myrna Diagnostics Sdn","url":"https://stock-news.laohu8.com/highlight/detail?id=2573958620","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573958620?lang=en_us&edition=fundamental","pubTime":"2025-10-06 16:32","pubTimestamp":1759739565,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251006:nFWN3VN1ML:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1161","02629"],"gpt_icon":0},{"id":"2573362095","title":"Mirxes Holding - Jv to Focus on Cancer Detection Tests in Malaysia","url":"https://stock-news.laohu8.com/highlight/detail?id=2573362095","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573362095?lang=en_us&edition=fundamental","pubTime":"2025-10-06 16:32","pubTimestamp":1759739565,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251006:nFWN3VN1ML:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["02629","BK1161"],"gpt_icon":0},{"id":"1170894051","title":"Hong Kong Stock Connect Biotech Stocks Trade Mixed in Positive Territory, MIRXES-B Surges 25% in Afternoon Session! Multi-Billion Private Equity Firms Increase Biotech Exposure on Dips, Pure-Play Biotech R&D ETF 520880 Attracts Strong Capital Inflows","url":"https://stock-news.laohu8.com/highlight/detail?id=1170894051","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1170894051?lang=en_us&edition=fundamental","pubTime":"2025-09-22 15:02","pubTimestamp":1758524570,"startTime":"0","endTime":"0","summary":"On September 19th, Hong Kong Stock Connect biotech stocks maintained positive momentum with fluctuations after an early morning rally and subsequent pullback. MIRXES-B stood out as the day's standout...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02629","BK1161","BK4614","HSTECH","07226","YANG","BK1574","HSCEI","06978","159992"],"gpt_icon":1},{"id":"1139458113","title":"Hong Kong Stock Alert | MIRXES-B (02629) Surges Over 35% Intraday to Record High as Singapore Cancer Screening Company Gets Added to Stock Connect","url":"https://stock-news.laohu8.com/highlight/detail?id=1139458113","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1139458113?lang=en_us&edition=fundamental","pubTime":"2025-09-15 14:40","pubTimestamp":1757918423,"startTime":"0","endTime":"0","summary":"MIRXES-B (02629) surged over 35% during intraday trading, reaching a record high of HK$59.5, representing a gain of more than 150% from its IPO price of HK$23.3. As of press time, the stock was...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["YANG","BK4614","02629","HSCEI","BK1161","07226"],"gpt_icon":1}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":38,"code":"91000000","status":"200"}]}}